Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,078 | 480 | 50.9% |
| Unspecified | $5,340 | 30 | 30.0% |
| Consulting Fee | $3,075 | 3 | 17.3% |
| Education | $330.19 | 5 | 1.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $4,086 | 22 | $0 (2024) |
| Eli Lilly and Company | $2,475 | 2 | $0 (2022) |
| ABBVIE INC. | $2,173 | 65 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $919.91 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $880.65 | 44 | $0 (2024) |
| Dermavant Sciences, Inc. | $863.35 | 38 | $0 (2024) |
| Amgen Inc. | $761.51 | 33 | $0 (2024) |
| UCB, Inc. | $668.13 | 37 | $0 (2024) |
| Lilly USA, LLC | $629.67 | 34 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $538.65 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,064 | 140 | SANOFI US SERVICES INC. ($1,974) |
| 2023 | $4,963 | 130 | SANOFI US SERVICES INC. ($2,112) |
| 2022 | $2,889 | 118 | Eli Lilly and Company ($900.00) |
| 2021 | $3,906 | 130 | Eli Lilly and Company ($1,575) |
All Payment Transactions
518 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.16 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Efficacy, Safety, PK, Biologics Monotherapy Study in Pts. with Moderate to Severe AD | SANOFI US SERVICES INC. | $4,086 | 22 |
| A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects With Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy | ABBVIE INC. | $1,254 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 904 | 1,197 | $153,010 | $46,337 |
| 2022 | 13 | 880 | 1,332 | $132,585 | $42,682 |
| 2021 | 10 | 688 | 1,022 | $68,532 | $35,628 |
| 2020 | 2 | 28 | 28 | $2,835 | $1,329 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 148 | $25,440 | $9,766 | 38.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 143 | 146 | $26,280 | $7,064 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $14,490 | $6,132 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 107 | $12,875 | $4,973 | 38.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 77 | $15,400 | $4,556 | 29.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 138 | 153 | $22,950 | $4,215 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $8,835 | $2,975 | 33.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 21 | $4,830 | $1,424 | 29.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 37 | 48 | $4,800 | $1,357 | 28.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 17 | $3,400 | $1,226 | 36.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 90 | 305 | $9,150 | $1,073 | 11.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 30 | $2,400 | $1,015 | 42.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,160 | $561.36 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 124 | $18,610 | $8,508 | 45.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 157 | 163 | $25,430 | $8,162 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $12,891 | $5,603 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 100 | $11,460 | $4,669 | 40.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 152 | 159 | $20,560 | $3,896 | 19.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 50 | 52 | $8,975 | $3,014 | 33.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 109 | 508 | $12,266 | $1,888 | 15.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $5,210 | $1,764 | 33.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 36 | 47 | $4,150 | $1,364 | 32.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 18 | 19 | $3,600 | $1,305 | 36.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 13 | 13 | $5,555 | $1,029 | 18.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 18 | 18 | $2,054 | $814.46 | 39.7% |
About Scarlett Bone, APRN
Scarlett Bone, APRN is a Family healthcare provider based in Fort Smith, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2018. The National Provider Identifier (NPI) number assigned to this provider is 1790274355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scarlett Bone, APRN has received a total of $17,823 in payments from pharmaceutical and medical device companies, with $6,064 received in 2024. These payments were reported across 518 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($9,078).
As a Medicare-enrolled provider, Bone has provided services to 2,500 Medicare beneficiaries, totaling 3,579 services with total Medicare billing of $125,975. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Fort Smith, AR
- Active Since 05/08/2018
- Last Updated 04/13/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1790274355
Products in Payments
- RINVOQ (Biological) $1,420
- DUPIXENT (Biological) $892.15
- VTAMA (Drug) $859.11
- TREMFYA (Drug) $769.27
- Otezla (Drug) $761.51
- Zoryve (Drug) $744.48
- TALTZ (Drug) $629.67
- SKYRIZI (Biological) $580.68
- Cimzia (Drug) $392.07
- EUCRISA (Drug) $388.99
- OPZELURA (Drug) $332.14
- ADBRY (Biological) $258.44
- Sotyktu (Drug) $244.38
- Bimzelx (Biological) $163.12
- LIBTAYO (Biological) $160.03
- AKLIEF (Drug) $148.27
- ILUMYA (Biological) $144.24
- COSENTYX (Drug) $143.90
- ORACEA (Drug) $127.11
- ENSTILAR (Drug) $113.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fort Smith
Nina Copeland, Apn, APN
Family — Payments: $205,036
Amanda Davis, Aprn, APRN
Family — Payments: $41,293
Mr. Nathan Williamson, Aprn, Np-C, APRN, NP-C
Family — Payments: $11,574
Yong Ounpraseuth, Aprn, APRN
Family — Payments: $9,150
Bentlee Rundell, Aprn, APRN
Family — Payments: $7,853
Mrs. Nycole Oliver, Aprn, APRN
Family — Payments: $7,446